Although the Supreme Court has recently increased its review of patent laws, the rulings have only eliminated deviations and reinforced precedent. However, the implications for nutraceutical companies is that their patent applications would have to represent a true invention and be very precise, rather than being a collection of scientific facts or trivial improvements. In his byline on www.nutraingredients-usa.com, Foley’s John Garvey discusses three recent cases reviewed by the Supreme Court and the impact of these decisions on dietary supplement and functional foods companies looking to patent their technologies.
Related Insights
August 22, 2025
Innovative Technology Insights
Banking and Digital Assets: Key Takeaways from the President’s Working Group Report
On July 30, 2025, the President’s Working Group on Digital Asset Markets (PWG) released “Strengthening American Leadership in Digital…
August 21, 2025
Innovative Technology Insights
Silicon, Sanctions, and Security: How National Security Laws Are Reshaping the Semiconductor Industry
Nick O'Keefe and Christopher Swift break down how evolving U.S. regulations—CFIUS, FIRRMA, export controls, and outbound investment rules—are reshaping semiconductor deals, and highlighting risks and best practices for successful transactions.
August 21, 2025
Foley Viewpoints
Securing Value: Patent Strategies for AI-Accelerated Drug Repurposing
Drug development can be slow, costly, and risky, often taking more than a decade and billions of dollars to bring a single therapy to the…